Case Study 06 – Head and Neck Cancer
Patient: 54 years – Male diagnosed with Squamous cell carcinoma of Buccal Mucosa Clinical Testing: Treatment Options: Overall preclinical and
OneCell Diagnostics is now 1Cell.Ai
Patient: 54 years – Male diagnosed with Squamous cell carcinoma of Buccal Mucosa Clinical Testing: Treatment Options: Overall preclinical and
Patient: 52 years – Male diagnosed with Adenocarcinoma Lung with Brain metastasis Clinical Testing: Treatment Options: Osimertinib is standard of
Patient: 54 years – Female diagnosed with Recurrent Metastatic Ovarian Adenocarcinoma Clinical Testing: Treatment Options: Co-occurring mutations in BRAF and
Patient: 67 years – Male diagnosed with Well-Differentiated Adenocarcinoma of Stomach Clinical Testing: Treatment Options: Various pre-clinical and clinical trials
Patient: 48 years – Female diagnosed with left breast cancer Clinical Testing: Treatment Options: The presence of HER2 amplification suggests
Patient: 52 years – Female diagnosed with Signet Ring Cell Adenocarcinoma of Colon Clinical Testing: Treatment Options: The presence of
Shaping the Future of Precision Oncology From Barcelona, 1Cell.Ai joined global leaders at ESMO 2024 to showcase our latest innovations
Driving Impact Through AI and Single-Cell Innovation At the world’s largest oncology meeting, 1Cell.Ai joined global leaders to present our
Expanding Access to Precision Diagnostics in Asia 1Cell.Ai was proud to participate in Medlab Asia 2024, where we showcased our
Pioneering the Future of Translational Cancer Research At AACR 2024, 1Cell.Ai showcased how AI, live-cell analytics, and multi-omics platforms are